NASDAQ:DHC · Diversified Healthcare Trust - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $366.47M | - | $388.71M | $382.71M | $386.86M | - | $373.64M | $371.39M | $370.78M | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $14.04M | - | $12.79M | $11.18M | $9.00M | - | $13.93M | $6.26M | $7.57M | - |
| Total Operating Expenses | $371.20M | - | $497.90M | $421.09M | $430.15M | - | $415.95M | $387.06M | $397.53M | - |
| D&A | $62.91M | - | $65.32M | $66.27M | $68.33M | - | $68.96M | $68.36M | $70.13M | - |
| Operating Income | ($42.75M) | - | ($168.79M) | ($93.88M) | ($10.42M) | - | ($99.07M) | ($85.38M) | ($87.97M) | - |
| Interest Expense | $37.05M | - | $48.89M | $50.93M | $57.58M | - | $59.44M | $58.70M | $57.58M | - |
| Income Tax | $622.0K | - | $337.0K | $843.0K | $49.0K | - | $148.0K | $170.0K | $187.0K | - |
| Net Income | ($43.27M) | - | ($164.04M) | ($91.64M) | ($8.99M) | - | ($98.69M) | ($97.86M) | ($86.26M) | - |
| EPS - Basic | ($0.18) | - | ($0.68) | ($0.38) | ($0.04) | - | ($0.41) | ($0.41) | ($0.36) | - |
| EPS - Diluted | ($0.18) | - | ($0.68) | ($0.38) | ($0.04) | - | ($0.41) | ($0.41) | ($0.36) | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $121.77M | $105.41M | $201.37M | $141.77M | $302.58M | $144.58M | $256.53M | $265.56M | $207.12M | $245.94M |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - |
| Current Assets | - | - | - | - | - | - | - | - | - | - |
| Total Assets | $4.27B | $4.36B | $4.68B | $4.76B | $5.00B | $5.14B | $5.29B | $5.33B | $5.35B | $5.45B |
| Current Liabilities | - | - | - | - | - | - | - | - | - | - |
| Long-term Debt | $2.44B | $2.44B | - | - | - | $3.05B | - | - | - | - |
| Total Liabilities | $2.65B | $2.70B | $3.00B | $2.90B | $3.05B | $3.18B | $3.24B | $3.18B | $3.10B | $3.11B |
| Stockholders' Equity | $1.62B | $1.67B | $1.69B | $1.85B | $1.95B | $1.96B | $2.05B | $2.51B | $2.58B | $2.34B |
| Retained Earnings | $1.08B | $1.12B | $1.14B | $1.31B | $1.40B | $1.41B | $1.50B | $1.59B | $1.69B | $1.78B |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $8.34M | - | - | - | ($3.24M) | - | - | - | $28.60M | - |
| Investing Cash Flow | $13.58M | - | - | - | $291.09M | - | - | - | ($58.84M) | - |
| Financing Cash Flow | ($3.87M) | - | - | - | ($131.05M) | - | - | - | ($8.56M) | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | -11.7% | - | -43.4% | -24.5% | -2.7% | - | -26.5% | -23.0% | -23.7% | - |
| EBITDA margin | 5.5% | - | -26.6% | -7.2% | 15.0% | - | -8.1% | -4.6% | -4.8% | - |
| Net margin | -11.8% | - | -42.2% | -23.9% | -2.3% | - | -26.4% | -26.3% | -23.3% | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 3.8% | - | 3.3% | 2.9% | 2.3% | - | 3.7% | 1.7% | 2.0% | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -1.0% | - | -3.5% | -1.9% | -0.2% | - | -1.9% | -1.8% | -1.6% | - |
| Return on equity | -2.7% | - | -9.7% | -4.9% | -0.5% | - | -4.8% | -3.9% | -3.3% | - |
| Return on invested capital | -0.8% | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | - | - | - | - | - | - | - | - | - | - |
| Quick ratio | - | - | - | - | - | - | - | - | - | - |
| Cash ratio | - | - | - | - | - | - | - | - | - | - |
| Leverage | ||||||||||
| Debt / Equity | 1.51 | 1.47 | - | - | - | 1.56 | - | - | - | - |
| Debt / Assets | 0.57 | 0.56 | - | - | - | 0.59 | - | - | - | - |
| Debt / EBITDA | 121.15 | - | - | - | - | - | - | - | - | - |
| Interest coverage | -1.2x | - | -3.5x | -1.8x | -0.2x | - | -1.7x | -1.5x | -1.5x | - |
| Equity multiplier | 2.63 | 2.62 | 2.77 | 2.56 | 2.56 | 2.62 | 2.58 | 2.13 | 2.07 | 2.33 |
| Liabilities / Assets | 0.62 | 0.62 | 0.64 | 0.61 | 0.61 | 0.62 | 0.61 | 0.60 | 0.58 | 0.57 |
| Efficiency | ||||||||||
| Asset turnover | 0.09 | - | 0.08 | 0.08 | 0.08 | - | 0.07 | 0.07 | 0.07 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -5.3% | - | 4.0% | 3.0% | 4.3% | - | 4.8% | 7.3% | 7.2% | - |
| Revenue CAGR (3y) | 1.9% | - | 6.4% | 6.9% | 7.6% | - | 3.5% | 2.4% | 0.7% | - |
| Revenue CAGR (5y) | 0.2% | - | -0.3% | -1.4% | -2.7% | - | 7.9% | 7.2% | 6.8% | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | -310.1% | - | -70.4% | -9.9% | 88.2% | - | -51.4% | 24.6% | -69.0% | - |
| Net income growth (YoY) | -381.6% | - | -66.2% | 6.4% | 89.6% | - | -50.0% | -34.8% | -63.8% | - |
| EPS growth (YoY) | -350.0% | - | -65.9% | 7.3% | 88.9% | - | -46.4% | -36.7% | -63.6% | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -16.8% | -15.0% | -17.6% | -26.1% | -24.6% | -16.2% | -16.1% | 0.0% | 0.0% | -11.4% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$1.51B totalSenior Housing Operating Portfolio Segment$1.31B · 87.1%
Medical Office And Life Science Portfolio Segment$193.81M · 12.9%
Product / service
$1.54B totalResident Fees And Services$1.31B · 85.4%
Rental Income$225.20M · 14.6%
Peer comparison
Same SIC group: Real Estate Investment Trusts
Comparing DIVERSIFIED HEALTHCARE TRUST against the 5 most active filers in the same SIC group.